Dr. Teedoh E. Beyslow, Sr, is currently the Deputy Director of Pharmacovigilance & Clinical Trials. He previously served as Director of the Inspectorate & Post-Market Surveillance Department for the LMHRA.
Dr. Beyslow previously worked with many health programs as a Pharmacy Technician and subsequently as a Pharmacist, including, but not limited to Partnership for Research on Ebola Vaccine in Liberia (PREVAIL) – PREVAIL-I (Ebola Vaccine Clinical Trail); PREVAIL-II (ZMapp Drug Clinical Trail); PREVAIL-III (Ebola Natural History Study); PREVAIL-IV (GS-5437 Drug Clinical Trail); PREVAIL-V/PREVAC (Vaccines Clinical Trail).
He has represented the Agency and made presentations at several fora highlighting the Authority's activities and achievements. He graduated from the University of Liberia with a Bachelor of Science Degree in Biology and a Bachelor of Pharmacy from the School of Pharmacy, University of Liberia. He went on to obtain certificates in the following areas: Introduction to Principles and Practice of Clinical Research, The National Institute of Health Clinical Center; Protecting Human Research Participants, The National Institute of Health (NIH) Office of Extramural Research; Good Clinical Practices, NIDA Clinical Trail Network; Cold Chain Principles and Procedures, PREVAIL; PREVAIL-IV Protocol Training, PREVAIL; PREVAIL-I Vaccine Trail, PREVAIL; PREVAIL-I Amendment Training, PREVAIL; Certificate on Aseptic Technique, Partnership for Research on Ebola Vaccine (PREVAIL).
Dr. Beyslow, Sr. obtained an M.Sc. degree in Epidemiology, from the Cuttington Graduate School and Professional Studies, Liberia. He is married with children.